XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Licensed Rights and Other Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2024
Licensed Rights and Other Intangible Assets [Abstract]  
Schedule of License Rights and Other Intangible Assets, Net The following provides information about our license rights and other intangible assets, net as of March 31, 2024 and December 31, 2023 (in thousands):
   March 31, 2024   December 31, 2023 
   Gross Carrying
Amount		   Accumulated
Amortization		   Net   Gross Carrying
Amount		   Accumulated
Amortization		   Net 
Intangible assets subject to amortization:                        
Hormone therapy drug patents  $6,819   $2,004   $4,815   $6,818   $1,871   $4,947 
Hormone therapy drug patents applied and pending approval   841    
—
    841    842    
—
    842 
Intangible assets subject to amortization   7,660    2,004    5,656    7,660    1,871    5,789 
Intangible assets not subject to amortization:                              
Trademarks/trade name rights   309    
—
    309    309    
—
    309 
License rights and other intangible assets, net  $7,969   $2,004   $5,965   $7,969   $1,871   $6,098 
Schedule of Intangible Assets Subject To Amortization Our intangible assets subject to amortization are expected to be amortized as follows (in thousands):
Year ending December 31,
2024  $400 
2025   445 
2026   445 
2027   445 
2028   446 
Thereafter   2,634 
Total  $4,815